Your search returned 15 studies. (Get alerts for new studies):
- Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma
Conditions: Urothelial Cancer - Muscle-invasive Urothelial Carcinoma
4 Locations available
- Familial and Atypical Urothelial Cancer Registry
Conditions: Urothelial Cancer - Renal Pelvis Cancer - Ureter Cancer - Bladder Cancer
5 Locations available
- Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
Conditions: Urothelial Carcinoma - Bladder Cancer
1 Location available
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Conditions: Bladder Cancer
1 Location available
- Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Conditions: Solid Tumor - Urethral Cancer
1 Location available
- Dose Dense MVAC for Muscle Invasive Bladder Cancer
Conditions: Muscle Invasive Bladder Cancer - High Risk Urothelial Carcinoma of the Upper Urinary Tracts
2 Locations available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
7 Locations available
- Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Conditions: Bladder Cancer - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) - Bladder (Urothelial, Transitional Ce
2 Locations available
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms - Neoplasms, Urethral - Ureter Cancer - Cancer of the Urethra - Urethral Cancer
1 Location available
- Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Conditions: Bladder Cancer
1 Location available
- Genetic Determinants of Response to Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer
Conditions: Urothelial Cancer
1 Location available
- A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Conditions: Bladder Cancer - Skin Cancers - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
1 Location available
- A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
Conditions: Urothelial Carcinoma
1 Location available
- Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer
Conditions: Urothelial Carcinoma of the Bladder
1 Location available
|